NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDA E-027-2010-0-US-02 Method of Protecting Against Stroke Through the Use of a Delta Opioid Peptide US National Stage 12/813,191 Abandoned
NIDDK E-177-2010-0-US-01 Thioether Prodrug Compositions As Anti-HIV And Anti-retroviral Agents US 61/353,274 Abandoned
NICHD E-247-2009-2-IL-06 Dendrimer Based Nanodevices For Therapeutic And Imaging Purposes IL National Stage 217035 Abandoned
NCI E-044-2003-0-US-06 Compositions Comprising Nucleic Acids Encoding HIV-1 Reverse Transcriptase CTL Epitopes US CON 12/796,614 8877914 Abandoned PDF
NIDDK E-064-2004-0-IT-43 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment IT EP 10165256.8 Expired
NIDDK E-064-2004-0-GR-41 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment GR EP 10165256.8 Expired
NIDDK E-064-2004-0-IE-42 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment IE EP 10165256.8 Expired
NIDDK E-064-2004-0-CZ-33 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment CZ EP 10165256.8 Expired
NIDDK E-064-2004-0-EE-36 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment EE EP 10165256.8 Expired
NIDDK E-064-2004-0-DK-35 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment DK EP 10165256.8 Expired
NIDDK E-064-2004-0-CY-32 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment CY EP 10165256.8 Expired
NIDDK E-064-2004-0-BE-29 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment BE EP 10165256.8 Expired
NIDDK E-064-2004-0-BG-30 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment BG EP 10165256.8 Expired
NIDDK E-064-2004-0-AL-27 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment AL EP 10165256.8 Expired
NIDDK E-064-2004-0-AT-28 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment AT EP 10165256.8 Expired
NIDDK E-064-2004-0-DE-34 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment DE EP 10165256.8 Expired
NIDDK E-064-2004-0-FR-39 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment FR EP 10165256.8 Expired
NIDDK E-064-2004-0-FI-38 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment FI EP 10165256.8 Expired
NIDDK E-064-2004-0-LV-47 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment LV EP 10165256.8 Expired
NIDDK E-064-2004-0-LT-45 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment LT EP 10165256.8 Expired
NIDDK E-064-2004-0-NL-50 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment NL EP 10165256.8 Expired
NIDDK E-064-2004-0-MC-48 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment MC EP 10165256.8 Expired
NIDDK E-064-2004-0-LI-44 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment LI EP 10165256.8 Expired
NIDDK E-064-2004-0-LU-46 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment LU EP 10165256.8 Expired
NIDDK E-064-2004-0-GB-40 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment GB EP 10165256.8 Expired
NIDDK E-064-2004-0-CH-31 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment CH EP 10165256.8 Expired
NIDDK E-064-2004-0-TR-56 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment TR EP 10165256.8 Expired
NIDDK E-064-2004-0-RO-52 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment RO EP 10165256.8 Expired
NIDDK E-064-2004-0-SE-53 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment SE EP 10165256.8 Expired
NIDDK E-064-2004-0-SK-55 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment SK EP 10165256.8 Expired
NIDDK E-064-2004-0-MK-49 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment MK EP 10165256.8 Expired
NIDDK E-064-2004-0-SI-54 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment SI EP 10165256.8 Expired
NIDDK E-064-2004-0-ES-37 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment ES EP 10165256.8 Expired
NIDDK E-064-2004-0-PT-51 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment PT EP 10165256.8 Expired
NHLBI E-321-2007-0-US-03 Apparatus For Countercurrent Chromatography US National Stage 12/746,436 9028693 Issued PDF
NCI E-221-2005-2-US-02 FAST ELECTRON PARAMAGNETIC RESONANCE IMAGING (EPRI) IN THE CW EPR MODE USING RAPID-SCAN IN THE PRESENCE OF ROTATING GRADIENTS AND DIRECT DETECTION WITH TRANSMIT/RECEIVE & DATA PROCESSING IN A DIGITAL SIGNAL PROCESSING PLATFORM US CON 12/794,695 8242778 Issued PDF
NIDDK E-226-2009-0-PCT-02 Use of Stamp Related Molecules in the Diagnosis and Inhibition of Ovarian Cancer Cells` PCT PCT PCT/US10/037452 Abandoned
NCI E-033-2008-0-GB-10 THERAPEUTIC APPLICATIONS OF P53 ISOFORMS IN REGENERATIVE MEDICINE, AGING AND CANCER GB EP 08850046.7 Issued
NCI E-033-2008-0-DE-09 THERAPEUTIC APPLICATIONS OF P53 ISOFORMS IN REGENERATIVE MEDICINE, AGING AND CANCER DE EP 08850046.7 Issued
NCI E-033-2008-0-FR-11 THERAPEUTIC APPLICATIONS OF P53 ISOFORMS IN REGENERATIVE MEDICINE, AGING AND CANCER FR EP 08850046.7 Issued
NCI E-200-2011-0-US-01 METHODS OF TREATING ABC-SUBTYPE OF DIFFUSE LARGE B-CELL LYMPHOMA (ABC-DLBCL) USING INHIBITORS OF BRUTON'S TYROSINE KINASE US 61/351,130 Abandoned
NCI E-098-2010-0-US-01 Drug Combination Of DNA Topoisomerase (TOP1) Inhibitors And Extracellular ATP Produces A Significant Increase In Beneficial Anti-carinoma Cytotoxicity US 61/350,660 Abandoned
NCI E-176-2010-1-US-01 Soluble Glypican-3 Inhibits Cancer Growth US 61/350,722 Abandoned
NIA E-146-1993-0-JP-54 METHOD OF TREATING ATHEROSCLEROSIS USING MICROTUBULE STABILIZING AGENT JP DIV 2010-125458 Expired
NIAID E-078-2009-0-DE-08 Antigenic Chimeric Tick-borne Encephalitis Virus/dengue Virus Type 4 Recombinant Viruses DE EP 10781321.4 Abandoned
NIAID E-078-2009-0-FR-09 Antigenic Chimeric Tick-borne Encephalitis Virus/dengue Virus Type 4 Recombinant Viruses FR EP 10781321.4 Abandoned
NIAID E-078-2009-0-IT-11 Antigenic Chimeric Tick-borne Encephalitis Virus/dengue Virus Type 4 Recombinant Viruses IT EP 10781321.4 Abandoned
NIAID E-078-2009-0-BE-07 Antigenic Chimeric Tick-borne Encephalitis Virus/dengue Virus Type 4 Recombinant Viruses BE EP 10781321.4 Abandoned
NIAID E-078-2009-0-EP-03 Antigenic Chimeric Tick-borne Encephalitis Virus/dengue Virus Type 4 Recombinant Viruses EP National Stage 10781321.4 Abandoned
NIAID E-078-2009-0-GB-10 Antigenic Chimeric Tick-borne Encephalitis Virus/dengue Virus Type 4 Recombinant Viruses GB EP 10781321.4 Abandoned